| abstract |
The present invention relates to novel beta-agonists of the general formula (I), where the radicals L, R 1 and R 2 have the meanings mentioned in the claims and the description, their racemates, their enantiomers, their diastereomers, their solvates, their hydrates, their mixtures and their salts, in particular their physiologically acceptable salts with inorganic or organic acids or bases, process for the preparation of these compounds and their use as medicaments. |